← Leaderboards
Mehmet Sofuoglu
University Of Minnesota Twin Cities
$12,955,155
Attributed
$14,108,982
Total exposure
18
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,108,982 · 18
By mechanism
R01$7,211,364 · 7
U54$3,555,256 · 2
R21$1,923,760 · 5
P50$574,550 · 1
K02$460,157 · 1
R03$383,895 · 1
Top collaborators
- Kimberly A Yonkers4 shared
- Elise Eva Devito2 shared
- Aryeh Isaac Herman2 shared
- Ismene L Petrakis2 shared
- Andrew J Waters2 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Dorothy K Hatsukami$58,862,572
- Paul R Pental$236,728
- Marilyn E. Carroll$16,962,565
- Sharon E Murphy$7,347,364
- Sheila Mary Specker$2,253,848
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsDoseNicotinePlacebosResponseClinical ResearchIntravenousRandomizedAttenuatedCigaretteSmokerFemaleClinical TrialsSelf AdministrationSmokingPharmacotherapyWithdrawalPatient Self-ReportInterestSmoking CessationCocaineTobaccoAddictionSeverities
Grant awards (54)
Addictive Threshold of Nicotine and the Impact of Sweeteners$348,552
U54 · FY2025 · DA · contact PI
Addictive Threshold of Nicotine and the Impact of Sweeteners$348,552
U54 · FY2024 · DA · contact PI
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate$392,233
R01 · FY2023 · DA · contact PI
Addictive Threshold of Nicotine and the Impact of Sweeteners$348,221
U54 · FY2023 · DA · contact PI
Research Project 3 : Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol$495,396
U54 · FY2022 · DA · contact PI
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate$392,233
R01 · FY2022 · DA · contact PI
Research Project 3 : Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol$527,615
U54 · FY2021 · DA · contact PI
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate$392,233
R01 · FY2021 · DA · contact PI
Research Project 3 : Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol$497,205
U54 · FY2020 · DA · contact PI
Research Project 3 : Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol$498,096
U54 · FY2019 · DA · contact PI
Nicotine Reinforcement and Aversion in Young Adult Light Smokers$524,222
R01 · FY2018 · DA · contact PI
Research Project 3 : Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol$491,619
U54 · FY2018 · DA · contact PI
Nicotine Reinforcement and Aversion in Young Adult Light Smokers$513,547
R01 · FY2017 · DA · contact PI
Nicotine Reinforcement and Aversion in Young Adult Light Smokers$519,699
R01 · FY2016 · DA · contact PI
COMT Inhibition as a Novel Treatment for Nicotine Addiction in Women$194,386
R21 · FY2016 · DA
Progesterone Augmentation for Smoking Cessation in Women$181,069
R21 · FY2016 · CA
Microglia as a Treatment Target for Alcohol Use Disorder$155,444
R21 · FY2016 · AA
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy$350,803
R01 · FY2015 · DA · contact PI
Progesterone Augmentation for Smoking Cessation in Women$217,283
R21 · FY2015 · CA
Microglia as a Treatment Target for Alcohol Use Disorder$188,169
R21 · FY2015 · AA
COMT Inhibition as a Novel Treatment for Nicotine Addiction in Women$163,625
R21 · FY2015 · DA
Cholinergic Enhancement as Treatment for Nicotine Addiction$200,553
R21 · FY2014 · DA · contact PI
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy$408,299
R01 · FY2013 · DA · contact PI
Cholinergic Enhancement as Treatment for Nicotine Addiction$175,553
R21 · FY2013 · DA · contact PI
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy$396,743
R01 · FY2012 · DA · contact PI
Pharmacotherapy & CM for Opioid and Cocaine Dependence$285,778
R01 · FY2012 · DA · contact PI
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy$357,459
R01 · FY2011 · DA · contact PI
Progesterone for Postpartum Cocaine Relapse$240,803
R21 · FY2011 · DA
Human Laboratory Studies for Stimulant Addiction$79,619
K02 · FY2011 · DA · contact PI
Cocaine Withdrawal and Pharmacotherapy Response$308,576
R01 · FY2010 · DA · contact PI
Progesterone for Postpartum Cocaine Relapse$206,875
R21 · FY2010 · DA
Sensitivity to intravenous nicotine: genetic moderators$190,983
R03 · FY2010 · DA · contact PI
Human Laboratory Studies for Stimulant Addiction$127,818
K02 · FY2010 · DA · contact PI
Cocaine Withdrawal and Pharmacotherapy Response$318,512
R01 · FY2009 · DA · contact PI
Sensitivity to intravenous nicotine: genetic moderators$192,912
R03 · FY2009 · DA · contact PI
GABA Medications for Tobacco Addiction$182,918
R01 · FY2009 · DA · contact PI
Human Laboratory Studies for Stimulant Addiction$126,360
K02 · FY2009 · DA · contact PI
Cocaine Withdrawal and Pharmacotherapy Response$311,140
R01 · FY2008 · DA · contact PI
GABA Medications for Tobacco Addiction$182,426
R01 · FY2008 · DA · contact PI
Human Laboratory Studies for Stimulant Addiction$126,360
K02 · FY2008 · DA · contact PI
Cocaine Withdrawal and Pharmacotherapy Response$327,586
R01 · FY2007 · DA · contact PI
GABA Medications and Cocaine Interaction in Humans$145,198
P50 · FY2007 · DA · contact PI
Progestrone and the Effects of Nicotine$211,355
R01 · FY2006 · DA · contact PI
GABA Medications for Tobacco Addiction$192,226
R01 · FY2006 · DA · contact PI
GABA Medications and Cocaine Interactions in Humans$144,604
P50 · FY2006 · DA · contact PI
Progestrone and the Effects of Nicotine$214,701
R01 · FY2005 · DA
GABA Medications and Cocaine Interactions in Humans$141,404
P50 · FY2005 · DA
Progestrone and the Effects of Nicotine$214,701
R01 · FY2004 · DA
GABA Medications and Cocaine Interactions in Humans$143,344
P50 · FY2004 · DA
Progestrone and the Effects of Nicotine$213,974
R01 · FY2003 · DA
PROGESTERONE TREATMENT ON EFFECTS OF STIMULANTS IN FEMALES$0
M01 · FY2002 · RR
PROGESTERONE TREATMENT ON EFFECTS OF STIMULANTS IN FEMALES$0
M01 · FY2002 · RR
PROGESTERONE TREATMENT ON EFFECTS OF STIMULANTS IN FEMALES$0
M01 · FY2001 · RR
PROGESTERONE TREATMENT ON EFFECTS OF STIMULANTS IN FEMALES$0
M01 · FY2000 · RR